ScholarIQanswers from OpenAlex

Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy

PaperCitations, authors & open-access status

Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy have?

ScholarIQcitation count

Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy has 22 citations in the OpenAlex counts ScholarIQ stores.

When was Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy published?

ScholarIQyear

Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy has 2021 year in the ScholarIQ index.

What is the open-access status of Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy?

ScholarIQoa status

Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy has gold oa status in the ScholarIQ index.

What is the DOI of Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy?

ScholarIQdoi

The DOI for Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy is on the source record.

What is the PMID of Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy?

ScholarIQpmid

The PMID for Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy is on the source record.

What is the OpenAlex record for Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy?

ScholarIQopenalex

The OpenAlex for Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial